Literature DB >> 14702957

Atazanavir sulphate.

Aarti Raja, John Lebbos, Peter Kirkpatrick.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14702957     DOI: 10.1038/nrd1232

Source DB:  PubMed          Journal:  Nat Rev Drug Discov        ISSN: 1474-1776            Impact factor:   84.694


× No keyword cloud information.
  5 in total

1.  A single centre cohort experience with a new once daily antiretroviral drug.

Authors:  J Stebbing; M Bower; P Holmes; B Gazzard; M Nelson
Journal:  Postgrad Med J       Date:  2006-05       Impact factor: 2.401

2.  Development and validation of a stability-indicating RP-HPLC method for estimation of atazanavir sulfate in bulk.

Authors:  S Dey; S Subhasis Patro; N Suresh Babu; P N Murthy; S K Panda
Journal:  J Pharm Anal       Date:  2013-12-31

3.  Comparison of the Efficacy and Safety of Atazanavir/Ritonavir Plus Hydroxychloroquine with Lopinavir/Ritonavir Plus Hydroxychloroquine in Patients with Moderate COVID-19, A Randomized, Double-blind Clinical Trial.

Authors:  Zahra Nekoukar; Shahram Ala; Siavash Moradi; Andrew Hill; Ali Reza Davoudi Badabi; Ahmad Alikhani; Shahriar Alian; Minoo Moghimi; Amir Mohammad Shabani; Hamideh Abbaspour Kasgari
Journal:  Iran J Pharm Res       Date:  2021       Impact factor: 1.696

Review 4.  Prioritization of Anti-SARS-Cov-2 Drug Repurposing Opportunities Based on Plasma and Target Site Concentrations Derived from their Established Human Pharmacokinetics.

Authors:  Usman Arshad; Henry Pertinez; Helen Box; Lee Tatham; Rajith K R Rajoli; Paul Curley; Megan Neary; Joanne Sharp; Neill J Liptrott; Anthony Valentijn; Christopher David; Steve P Rannard; Paul M O'Neill; Ghaith Aljayyoussi; Shaun H Pennington; Stephen A Ward; Andrew Hill; David J Back; Saye H Khoo; Patrick G Bray; Giancarlo A Biagini; Andrew Owen
Journal:  Clin Pharmacol Ther       Date:  2020-06-14       Impact factor: 6.903

5.  Stacking up the armory against viruses.

Authors:  Bert M Klebl
Journal:  Drug Discov Today       Date:  2004-02-15       Impact factor: 7.851

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.